Alkaline phosphatase (ALP)

Physiological Role

Alkaline phosphatase refers to a family of enzymes that catalyze the hydrolysis of phosphate groups at alkaline pH. They are distributed across several tissues: liver, biliary tract, bone, intestine, and placenta during pregnancy. Blood measurement reflects the combined activity of these sources, with hepatobiliary and bone fractions predominating in adults.

The hepatobiliary isoform is anchored in the membrane of cells lining the biliary canaliculi. It rises when bile flow slows, a phenomenon called cholestasis. The bone fraction is produced by osteoblasts, the cells responsible for bone formation and mineralization. Its circulating level reflects bone remodeling activity. The intestinal fraction, more discreet, varies after meals in individuals with blood types O and B.

Beyond this enzymatic function, alkaline phosphatase is studied for its role in vascular and bone calcification. It cleaves pyrophosphate, a natural inhibitor of mineralization, and thus conditions the balance between solubility and mineral deposition. This dual localization, both bone and vascular, explains why its interpretation benefits from combination with other markers.

Reference Ranges

These reference ranges are derived from scientific literature and may differ from your laboratory's reference values.

Source : Li JW et al. / PLoS One (méta-analyse, 147 634 patients fonction rénale préservée) (2014)

Biological Significance

Alkaline phosphatase in the optimal range reflects a stable balance between the various tissue sources: liver, biliary tract, and bone remodeling. This is the favorable scenario for a longevity trajectory, associated in prospective cohorts with reduced mortality.

Elevated values may reflect several origins. A predominant hepatobiliary fraction suggests a slowing of bile flow, often read alongside GGT. When GGT rises simultaneously, the origin is likely hepatic. When GGT remains in the optimal zone, the origin is more likely bone-related, indicating active remodeling. The reference meta-analysis by Li and colleagues shows a linear association between elevated values and all-cause mortality beyond a defined threshold.

Very low values are rare but informative. They may reflect insufficient intake of zinc, magnesium, or vitamin B6, the direct cofactors of the enzyme. Hypothyroidism or prolonged malnutrition can also lower the level. A genetic form called hypophosphatasia, rarer, is characterized by sustained reduced enzymatic activity.

The most refined reading combines alkaline phosphatase with ALT, GGT, vitamin D, and key minerals. It is this cross-reading that allows distinguishing a hepatic origin from a bone origin and directing follow-up toward the relevant axes. The trend over time matters more than an isolated value.

Influencing Factors

Diet. Zinc and magnesium intake directly conditions alkaline phosphatase activity, as both minerals are structural cofactors of the enzyme. Insufficient vitamin B6 intake can also affect the measurement, the vitamin being involved in its metabolic balance. A diet low in protein or chronically restrictive tends to reduce the level.

Fat-soluble vitamins. Vitamin D and vitamin K2 influence alkaline phosphatase through the bone pathway. Vitamin D modulates osteoblast activity, and vitamin K2 directs mineralization toward bone tissue rather than vascular tissue. Adequate intake of these two vitamins contributes to a balanced bone profile.

Genetics. Polymorphisms of the ALPL gene, which encodes the tissue-nonspecific isoform of the enzyme, modulate the baseline level. The most pronounced forms of these variations correspond to hypophosphatasia, a rare condition characterized by sustained low enzymatic activity.

Medications. Some anticonvulsants, contraceptive hormones, and certain antibiotics can modulate values. Long-term corticosteroids also influence bone remodeling and thus the bone fraction. Any supplementation or medication should be reported during interpretation.

Life cycle. Pregnancy raises alkaline phosphatase due to the appearance of the placental isoform, particularly in the third trimester. Bone growth during adolescence naturally increases the level, which remains higher than in adults until skeletal maturation is complete.

Blood type and dietary habits. Individuals with blood types O and B have a more pronounced intestinal fraction, particularly after fat-rich meals. This variation is physiological and is not associated with increased risk.

Physical activity. Regular exercise, particularly weight-bearing activities, stimulates bone remodeling and can transiently raise the bone fraction of alkaline phosphatase. This effect reflects increased osteoblastic activity, a sign of dynamic bone capital.

In the Singular Formula

Alkaline phosphatase plays a particular role in the Singular formulation engine: it conditions the interpretation of vitamin B6 status. This enzyme participates in the metabolism of PLP, the active form of B6 measured in blood. An alkaline phosphatase that is too high or too low makes the PLP reading less reliable.

When alkaline phosphatase falls into the very low zone, the engine applies a cautious maintenance dose of vitamin B6. This logic reflects the uncertainty linked to a B6 status that is difficult to interpret in this context. When alkaline phosphatase falls into the very high zone and PLP appears low or very low, the situation is analogous. The engine then applies a maintenance dose rather than reinforced supplementation. The combined reading avoids over-supplementing based on a biased PLP.

Beyond these rules, bioactives linked to alkaline phosphatase through their direct influence on cofactors and bone remodeling are also part of the formula. Zinc and magnesium, structural cofactors of the enzyme, are included. Vitamin D3 and vitamin K2-MK7, studied for their role in bone mineralization, are also integrated. On the hepatic axis, N-acetylcysteine and curcumin support the cellular defense pathways of the liver.

Alkaline phosphatase completes the liver panel formed with ALT and GGT. This triad allows the formulation engine to distinguish a pure hepatic load from a bone or mixed hepatobiliary signal. Singular measures these three markers together to enable this cross-reading.

Scientific Studies

Frequently Asked Questions